Eli Lilly and Company
TREM2 ANTIBODIES AND USES THEREOF
Last updated:
Abstract:
The present invention relates to TREM2 antibodies, and uses thereof, for treating diseases such as neurodegenerative diseases.
Status:
Application
Type:
Utility
Filling date:
5 May 2022
Issue date:
8 Sep 2022